HOME >> BIOLOGY >> NEWS
Severe Falciparum Malaria Increases In Honduras

Washington, Sept. 1, 1998--A dramatic increase has been reported in falciparum malaria in northern Honduras by a group of researchers writing in the current issue of the Pan American Journal of Public Health.

"Over the past few years there has been a striking increase in malaria in Honduras," the journal said. Reported cases rose from 52,110 in 1994 to 75,565 in 1996, a 45% increase in three years. The journal is published by the Pan American Health Organization.

Malaria is a significant cause of death and disease worldwide. Each year, malaria parasites infect between 300 and 500 million people and cause more than 2.7 million deaths. Plasmodium vivax is reported to be the infecting strain in some 98% of Honduran malaria cases, the journal said. "However, we recently documented a much higher proportionate increase of falciparum malaria in northern Honduras." This type of malaria is a much more severe form of the disease.

The authors, Carol J. Palmer and colleagues from the University of Miami School of Medicine and John F. Lindo of the University of the West Indies in Jamaica, said they investigated a recent outbreak in the Coln region, and tested residents of that area as well as the city of San Pedro Sula. They collected 202 blood samples and found that 47% were positive for malaria parasites. Plasmodium vivax, the milder form, was present in 79% of the infected rural patients and 100% of the infected city patients.

The more severe form, Plasmodium falciparum, was present in 21% of the rural patients, the journal said. In 1996, this form of malaria accounted for 3.5% of the malaria cases in that area.

Possible explanations include increased transmission by mosquitoes as a result of a long rainy season, an increase in the non-immune population, development of chloroquine resistance by Plasmodium falciparum parasites, and underdiagnosis, the authors said.

"The widespread development
'"/>

Contact: Daniel Epstein
epsteind@paho.org
(202) 974-3459
Pan American Health Organization
1-Sep-1998


Page: 1 2

Related biology news :

1. Severe depression associated with greater number of nerve cells in thalamus region of brain
2. Severe kidney disease in blacks linked to genes on two chromosomes
3. Severe Pain Following Shingles Safely Relieved In Clinical Trial Of Anti-Convulsant Drug Gabapentin
4. Scientists Find Gene For Severe Form Of Epilepsy
5. Common Anti-Viral Medication Prevents Severe Eye Herpes
6. Common Food Dye Can Cause Severe Allergic Reactions
7. Oral Vaccine Protects Infants From Severe Rotavirus Diarrhea
8. GenVec, U.S. NMRC, and PATHs Malaria Vaccine Initiative partner to expand malaria vaccine efforts
9. Malaria rise in Africa parallels warming trends
10. Pan-African Malaria Conference November 17-22 in Arusha, Tanzania
11. Multilateral Initiative on Malaria Secretariat to move to Sweden

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/15/2016)... , June 15, 2016 ... market report titled "Gesture Recognition Market by Application Market - Global ... 2016 - 2024". According to the report, the  global ... billion in 2015 and is estimated to grow ... 48.56 billion by 2024.  Increasing application ...
(Date:6/7/2016)... -- Syngrafii Inc. and San Antonio Credit Union (SACU) ... Syngrafii,s patented LongPen™ eSignature "Wet" solution into SACU,s ... in greater convenience for SACU members and operational ... document workflow and compliance requirements. Logo ... Highlights: ...
(Date:6/2/2016)... The Weather Company , an IBM Business (NYSE: IBM ... which consumers will be able to interact with IBM Watson ... or text and receive relevant information about the product or ... long sought an advertising solution that can create a one-to-one ... valuable; and can scale across millions of interactions and touchpoints. ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the Industry ... Supplyframe Design Lab . Located in Pasadena, Calif., the Design Lab’s mission ... hardware projects are designed, built and brought to market. , The Design Lab ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... 23, 2016 On Wednesday, June 22, ... down 0.22%; the Dow Jones Industrial Average edged 0.27% lower ... 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on the following ... Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing ...
(Date:6/23/2016)... Windsor, Connecticut (PRWEB) , ... June 23, 2016 ... ... will introduce a new line of intelligent tools designed, tuned and optimized exclusively ... place September 12–17 in Chicago. The result of a collaboration among several companies ...
Breaking Biology Technology:
Cached News: